In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
In the biggest CRO takeover in years, ICON doles out $12B for PRA Health Sciences to focus on decentralised clinical work
ICON will acquire PRA Health Sciences for $12 billion in a move that will shake up the hightest rungs of a fragmented market.
-
Deal watch: ICON, PRA Health form massive CRO In $12bn merger
ICON acquires PRA Health Sciences to form a world-leader CRO.
-
ICON eyes growing virtual clinical trial market with $12 bln PRA Health deal
An article reporting on ICON's acquisition of contract research organisation PRA Health Sciences.
-
COVID trials vaccine firm ICON announces €10bn US takeover deal
ICON has announced one of the biggest takeover deals in Irish corporate history.
-
ICON to buy contract researcher PRA Health for $12B
ICON will buy PRA Health Sciences for about $12 billion in cash and stock, snapping up one of the larger independent companies in the drugmaker services business.
-
ICON plc acquires PRA Health Sciences Inc. in $12 billion acquisition
In a cash and stock transaction value of approximately $12 billion, ICON plc has announced its acquisition of PRA Health Sciences as part of a focus on innovative and high-quality clinical trials.
-
CRO consolidation continues with ICON buying PRA Health Sciences for $12B
ICON is set to acquire rival PRA Health Sciences in a $12 billion deal that will vault the combined company into second place among clinical trial services providers.
-
How to manage the impact of COVID-19 on IVDR timelines
Angela Brown and Nicole A. Cowan, Director examine how IVD manufacturers can meet 2022 deadlines despite the COVID-19 pandemic.
-
Decentralised, hybrid or traditional: Choosing the best option for your clinical trial
In this article, EB McLindon offers insights to help sponsors decide which approach is most optimal for a clinical trial.
-
.jpg?w=545&itok=brD_PcbH "EPR-Logo-Thumbnail-(1)")
The current and future landscape of HIV treatments and vaccines
Dr. Caroline Forkin discusses the current status of HIV treatments and potential for researchers to develop a vaccine.
.jpg?w=340&itok=E3i_e4OT "EPR-Logo-Thumbnail-(1)"){kind=icon}